Ovid Therapeutics Inc. Total Contract Liability
Ovid Therapeutics Inc. (OVID) had Total Contract Liability of $718.00 thousand as of 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Balance Sheet › Liabilities
us-gaap:ContractWithCustomerLiability · last filed 2025-11-12
- 2025-09-30: Contract with Customer, Liability $718.00K.
- 2025-06-30: Contract with Customer, Liability $718.00K.
- 2024-12-31: Contract with Customer, Liability $0.00.
| Period end | Contract with Customer, Liability |
|---|---|
| 2025-09-30 | $718.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $718.00K 10-Q · filed 2025-08-13 |
| 2024-12-31 | $0.00 10-Q · filed 2025-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |